France
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 1.81 B
|
June 30, 2024 | USD 11.08 | 0.25% |
|
France |
|
2 |
USD 1.20 B
|
Dec. 31, 2023 | USD 121.52 | 0.77% |
|
France |
|
3 |
USD 566.11 M
|
Dec. 31, 2023 | USD 28.77 | 0.25% |
|
France |
|
4 |
USD 253.01 M
|
Dec. 31, 2023 | USD 28.61 | 0.98% |
|
France |
|
5 |
USD 81.79 M
|
Dec. 31, 2023 | USD 7.91 | 1.05% |
|
France |
|
6 |
USD 58.36 M
|
Dec. 31, 2023 | USD 26.53 | -0.92% |
|
France |
|
7 |
USD 55.05 M
|
Dec. 31, 2023 | USD 3.47 | -1.52% |
|
France |
|
8 |
USD 50.44 M
|
June 30, 2024 | USD 3.56 | -2.04% |
|
France |
|
9 |
USD 45.06 M
|
Dec. 31, 2023 | USD 1.18 | 2.98% |
|
France |
|
10 |
USD 37.62 M
|
Dec. 31, 2023 | USD 0.65 | 1.19% |
|
France |
|
11 |
USD 30.46 M
|
Dec. 31, 2023 | USD 2.44 | 6.09% |
|
France |
|
12 |
USD 25.08 M
|
Dec. 31, 2023 | USD 3.55 | 2.04% |
|
France |
|
13 |
USD 16.83 M
|
Dec. 31, 2023 | USD 4.49 | 2.38% |
|
France |
|
14 |
USD 9.29 M
|
Dec. 31, 2023 | USD 1.45 | 1.71% |
|
France |
|
15 |
USD 7.21 M
|
Dec. 31, 2023 | USD 7.60 | -5.89% |
|
France |
|
16 |
USD 4.25 M
|
Dec. 31, 2023 | USD 3.60 | 1.72% |
|
France |
|
17 |
USD 2.54 M
|
Dec. 31, 2023 | USD 1.58 | 0.91% |
|
France |
|
18 |
USD 1.04 M
|
Dec. 31, 2023 | USD 3.87 | -3.39% |
|
France |
The Medical Instruments company in France with the highest Current Liabilities is Ramsay Générale de Santé SA (Paris Stock Exchange: GDS.PA) at USD 1.81 B.
The Medical Instruments company in France with the lowest Current Liabilities is Predilife S.A. (Paris Stock Exchange: ALPRE.PA) at USD 1.04 M.
The top 10 Medical Instruments companies in France by Current Liabilities are Ramsay Générale de Santé SA, bioMérieux S.A., Lisi S.A., Guerbet SA, Lumibird SA, Eurobio Scientific SA, Nanobiotix S.A., Amplitude Surgical SA, Biosynex SA and Novacyt S.A..
The bottom 10 Medical Instruments companies in France by Current Liabilities are Predilife S.A., Ikonisys S.A., MEMSCAP, S.A., i2S SA, Affluent Medical SA, Euromedis Groupe, Median Technologies SA, EDAP TMS S.A., Novacyt S.A. and Biosynex SA.